Antibody-Drug Conjugates Take Breast Cancer Field by Storm
Antibody-drug conjugates (ADCs) have taken the field of breast cancer by storm and appear poised to expand their reach into earlier lines of therapy and early-stage disease, a breast cancer specialist said here. ADCs offer an “exciting and effective drug delivery system” for multiple subtypes of metastatic breast cancer, and ongoing clinical trials are exploring […]